GENENTECH, INC. et al v. CELLTRION, INC. et al > Summary

Court Case Number 1:18-cv-00574

Filing Date Jan 12, 2018

Termination Date Nov 1, 2018

Court New Jersey District Court

Status Dismissed - Voluntarily

JudgesRenee Marie Bumb, Karen M. Williams

Cause

15:1126 Patent Infringement

Related Patents

Doc No	Title	Issue date
09714293	Production of proteins in glutamine-free cell culture media	Jul 25, 2017
09504744	Treatment of diffuse large-cell lymphoma with anti-CD20 antibody	Nov 29, 2016
09487809	Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase	Nov 8, 2016
09428766	Protein expression from multiple nucleic acids	Aug 30, 2016
09428548	Enhanced protein purification through a modified protein A elution	Aug 30, 2016
09296821	Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies	Mar 29, 2016
09080183	Promoter	Jul 14, 2015
09047438	Chromatography equipment characterization	Jun 2, 2015
08822655	Pre-filtration adjustment of buffer solutes	Sep 2, 2014
08821873	Treatment of diffuse large-cell lymphoma with anti-CD20 antibody	Sep 2, 2014
08771988	Protein expression from multiple nucleic acids	Jul 8, 2014
08710196	Protein purification	Apr 29, 2014
08633302	Variable tangential flow filtration	Jan 21, 2014
08574869	Prevention of disulfide bond reduction during recombinant production of polypeptides	Nov 5, 2013
08557255	High frequency application of botulinum toxin therapy	Oct 15, 2013
08557244	Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody	Oct 15, 2013
08545843	Treatment of vasculitis	Oct 1, 2013
08512983	Production of proteins in glutamine-free cell culture media	Aug 20, 2013
08460895	Method for producing recombinant proteins with a constant content of pCO2 in the medium	Jun 11, 2013
08357301	Chromatography equipment characterization	Jan 22, 2013
08329172	Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody	Dec 11, 2012
08206711	Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies	Jun 26, 2012
08044017	Protein purification	Oct 25, 2011
07976838	Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor	Jul 12, 2011
07923221	Methods of making antibody heavy and light chains having specificity for a desired antigen	Apr 12, 2011
07820161	Treatment of autoimmune diseases	Oct 26, 2010
07807799	Reducing protein A leaching during protein A affinity chromatography	Oct 5, 2010
07682612	Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody	Mar 23, 2010
07485704	Reducing protein A leaching during protein A affinity chromatography	Feb 3, 2009
07390660	Methods for growing mammalian cells in vitro	Jun 24, 2008
07381560	Expression and use of anti-CD20 antibodies	Jun 3, 2008
06716602	Metabolic rate shifts in fermentations expressing recombinant proteins	Apr 6, 2004
06620918	Separation of polypeptide monomers	Sep 16, 2003
06610516	Cell culture process	Aug 26, 2003
06586206	Methods for making recombinant proteins using apoptosis inhibitors	Jul 1, 2003
06489447	Protein purification	Dec 3, 2002
06455043	Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody	Sep 24, 2002
06417335	Protein purification	Jul 9, 2002
06331415	Methods of producing immunoglobulins, vectors and transformed host cells for use therein	Dec 18, 2001
06242177	Methods and compositions for secretion of heterologous polypeptides	Jun 5, 2001
06121428	Protein recovery	Sep 19, 2000

Lawsuits

GENENTECH, INC. et al v. CELLTRION, INC. et al > Summary

Plaintiff

Defendant

Plaintiff Attorneys

Defendant Attorneys

Counter Defendant

Counter Claimant

Cause

Related Patents